{"uri": "eng-9410432", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Vaccine", "type": "wiki", "score": 100, "label": {"eng": "Vaccine"}}, {"uri": "http://en.wikipedia.org/wiki/Chikungunya", "type": "wiki", "score": 87, "label": {"eng": "Chikungunya"}}, {"uri": "http://en.wikipedia.org/wiki/Valneva_COVID-19_vaccine", "type": "wiki", "score": 83, "label": {"eng": "Valneva COVID-19 vaccine"}}, {"uri": "http://en.wikipedia.org/wiki/Japanese_encephalitis_vaccine", "type": "wiki", "score": 81, "label": {"eng": "Japanese encephalitis vaccine"}}, {"uri": "http://en.wikipedia.org/wiki/Cholera_vaccine", "type": "wiki", "score": 76, "label": {"eng": "Cholera vaccine"}}, {"uri": "http://en.wikipedia.org/wiki/Euro", "type": "wiki", "score": 73, "label": {"eng": "Euro"}}, {"uri": "http://en.wikipedia.org/wiki/Zika_virus", "type": "wiki", "score": 71, "label": {"eng": "Zika virus"}}, {"uri": "http://en.wikipedia.org/wiki/Advisory_Committee_on_Immunization_Practices", "type": "wiki", "score": 68, "label": {"eng": "Advisory Committee on Immunization Practices"}}, {"uri": "http://en.wikipedia.org/wiki/Lyme_disease", "type": "wiki", "score": 68, "label": {"eng": "Lyme disease"}}, {"uri": "http://en.wikipedia.org/wiki/Pfizer", "type": "wiki", "score": 66, "label": {"eng": "Pfizer"}}, {"uri": "http://en.wikipedia.org/wiki/Research_and_development", "type": "wiki", "score": 63, "label": {"eng": "Research and development"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 61, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Booster_dose", "type": "wiki", "score": 59, "label": {"eng": "Booster dose"}}, {"uri": "http://en.wikipedia.org/wiki/Vaccination", "type": "wiki", "score": 59, "label": {"eng": "Vaccination"}}, {"uri": "http://en.wikipedia.org/wiki/Coronavirus", "type": "wiki", "score": 55, "label": {"eng": "Coronavirus"}}, {"uri": "http://en.wikipedia.org/wiki/Europe", "type": "loc", "score": 52, "label": {"eng": "Europe"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/United_States", "type": "loc", "score": 52, "label": {"eng": "United States"}, "location": {"type": "country", "label": {"eng": "United States"}}}, {"uri": "http://en.wikipedia.org/wiki/Pediatrics", "type": "wiki", "score": 51, "label": {"eng": "Pediatrics"}}, {"uri": "http://en.wikipedia.org/wiki/Brazil", "type": "loc", "score": 51, "label": {"eng": "Brazil"}, "location": {"type": "country", "label": {"eng": "Brazil"}}}, {"uri": "http://en.wikipedia.org/wiki/Valneva_SE", "type": "org", "score": 50, "label": {"eng": "Valneva SE"}}, {"uri": "http://en.wikipedia.org/wiki/Mosquito", "type": "wiki", "score": 50, "label": {"eng": "Mosquito"}}, {"uri": "http://en.wikipedia.org/wiki/Scotland", "type": "loc", "score": 49, "label": {"eng": "Scotland"}, "location": {"type": "place", "label": {"eng": "Scotland"}, "country": {"type": "country", "label": {"eng": "United Kingdom"}}}}, {"uri": "http://en.wikipedia.org/wiki/Antibody", "type": "wiki", "score": 48, "label": {"eng": "Antibody"}}, {"uri": "http://en.wikipedia.org/wiki/Canada", "type": "loc", "score": 47, "label": {"eng": "Canada"}, "location": {"type": "country", "label": {"eng": "Canada"}}}, {"uri": "http://en.wikipedia.org/wiki/Bavarian_Nordic", "type": "org", "score": 41, "label": {"eng": "Bavarian Nordic"}}, {"uri": "http://en.wikipedia.org/wiki/Japanese_encephalitis", "type": "wiki", "score": 40, "label": {"eng": "Japanese encephalitis"}}, {"uri": "http://en.wikipedia.org/wiki/Pipeline_transport", "type": "wiki", "score": 39, "label": {"eng": "Pipeline transport"}}, {"uri": "http://en.wikipedia.org/wiki/Asia", "type": "loc", "score": 39, "label": {"eng": "Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/France", "type": "loc", "score": 38, "label": {"eng": "France"}, "location": {"type": "country", "label": {"eng": "France"}}}, {"uri": "http://en.wikipedia.org/wiki/Developing_country", "type": "loc", "score": 35, "label": {"eng": "Developing country"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/New_Zealand", "type": "loc", "score": 32, "label": {"eng": "New Zealand"}, "location": {"type": "country", "label": {"eng": "New Zealand"}}}, {"uri": "http://en.wikipedia.org/wiki/Australia", "type": "loc", "score": 32, "label": {"eng": "Australia"}, "location": {"type": "country", "label": {"eng": "Australia"}}}, {"uri": "http://en.wikipedia.org/wiki/European_Union", "type": "loc", "score": 25, "label": {"eng": "European Union"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Solna_Municipality", "type": "loc", "score": 24, "label": {"eng": "Solna Municipality"}, "location": {"type": "place", "label": {"eng": "Solna Municipality"}, "country": {"type": "country", "label": {"eng": "Sweden"}}}}, {"uri": "http://en.wikipedia.org/wiki/Livingston,_West_Lothian", "type": "loc", "score": 24, "label": {"eng": "Livingston, West Lothian"}, "location": {"type": "place", "label": {"eng": "Livingston, West Lothian"}, "country": {"type": "country", "label": {"eng": "United Kingdom"}}}}, {"uri": "http://en.wikipedia.org/wiki/Sweden", "type": "loc", "score": 24, "label": {"eng": "Sweden"}, "location": {"type": "country", "label": {"eng": "Sweden"}}}, {"uri": "http://en.wikipedia.org/wiki/Saint-Herblain", "type": "loc", "score": 21, "label": {"eng": "Saint-Herblain"}, "location": {"type": "place", "label": {"eng": "Saint-Herblain"}, "country": {"type": "country", "label": {"eng": "France"}}}}, {"uri": "http://en.wikipedia.org/wiki/Thailand", "type": "loc", "score": 19, "label": {"eng": "Thailand"}, "location": {"type": "country", "label": {"eng": "Thailand"}}}, {"uri": "http://en.wikipedia.org/wiki/Instituto_Butantan", "type": "org", "score": 16, "label": {"eng": "Instituto Butantan"}}, {"uri": "http://en.wikipedia.org/wiki/Vibrio_cholerae", "type": "loc", "score": 16, "label": {"eng": "Vibrio cholerae"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Southeast_Asia", "type": "loc", "score": 16, "label": {"eng": "Southeast Asia"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Americas", "type": "loc", "score": 16, "label": {"eng": "Americas"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Africa", "type": "loc", "score": 16, "label": {"eng": "Africa"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Government_of_the_United_Kingdom", "type": "org", "score": 8, "label": {"eng": "Government of the United Kingdom"}}], "eventDate": "2024-03-20", "totalArticleCount": 9, "title": {"eng": "Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com"}, "summary": {"eng": "Valneva SE (VLA), a specialty vaccine company, has reported a strong financial performance in its full-year 2023 results, with total product sales increasing by 26% from the previous year. The company has made significant progress in its research and development (R&D) pipeline, including receiving FDA approval for the world's first chikungunya vaccine, IXCHIQ, and initiating a Phase III study with Pfizer (NYSE:PFE) for a Lyme disease vaccine.\n\nValneva has also outlined its strategic focus on beco"}, "location": {"type": "place", "label": {"eng": "Scotland"}, "country": {"type": "country", "label": {"eng": "United Kingdom"}}}, "categories": [{"uri": "dmoz/Society/Issues/Business", "label": "dmoz/Society/Issues/Business", "wgt": 100}, {"uri": "dmoz/Health/Child_Health/Immunizations", "label": "dmoz/Health/Child Health/Immunizations", "wgt": 76}, {"uri": "news/Business", "label": "news/Business", "wgt": 99}], "articleCounts": {"eng": 9}, "sentiment": 0.1686274509803922, "wgt": 448588800, "relevance": 1}